ASX - By Stock
|
CMB |
Re:
Ann: Trading Halt
|
|
TILLI
|
8 |
3.2K |
2 |
11/08/20 |
11/08/20 |
ASX - By Stock
|
8
|
3.2K
|
2
|
|
ASX - By Stock
|
CMB |
Re:
Ann: Kyocera completes Progenza Due Diligence
|
|
TILLI
|
31 |
9.9K |
2 |
02/07/20 |
02/07/20 |
ASX - By Stock
|
31
|
9.9K
|
2
|
|
ASX - By Stock
|
CMB |
Re:
Ann: Kyocera completes Progenza Due Diligence
|
|
TILLI
|
31 |
9.9K |
0 |
28/05/20 |
28/05/20 |
ASX - By Stock
|
31
|
9.9K
|
0
|
|
ASX - By Stock
|
CMB |
Re:
Ann: Kyocera completes Progenza Due Diligence
|
|
TILLI
|
31 |
9.9K |
0 |
18/05/20 |
18/05/20 |
ASX - By Stock
|
31
|
9.9K
|
0
|
|
ASX - By Stock
|
CMB |
Re:
Ann: Kyocera completes Progenza Due Diligence
|
|
TILLI
|
31 |
9.9K |
5 |
18/05/20 |
18/05/20 |
ASX - By Stock
|
31
|
9.9K
|
5
|
|
ASX - By Stock
|
CMB |
Re:
Ann: Appendix 4C - Quarterly
|
|
TILLI
|
16 |
12K |
1 |
01/02/20 |
01/02/20 |
ASX - By Stock
|
16
|
12K
|
1
|
|
ASX - By Stock
|
CMB |
Re:
Ann: Clarification to Announcement
|
|
TILLI
|
3 |
1.8K |
3 |
30/08/19 |
30/08/19 |
ASX - By Stock
|
3
|
1.8K
|
3
|
|
ASX - By Stock
|
CMB |
Re:
Ann: Restructuring results in 50% reduction in operating costs
|
|
TILLI
|
3 |
3.1K |
2 |
20/08/19 |
20/08/19 |
ASX - By Stock
|
3
|
3.1K
|
2
|
|
ASX - By Stock
|
CMB |
Re:
Ann: Regeneus Appoints International Directors for Global Growth
|
|
TILLI
|
27 |
14K |
1 |
15/05/19 |
15/05/19 |
ASX - By Stock
|
27
|
14K
|
1
|
|
ASX - By Stock
|
CMB |
Re:
Volume and price
|
|
TILLI
|
93 |
44K |
2 |
27/08/18 |
27/08/18 |
ASX - By Stock
|
93
|
44K
|
2
|
|
ASX - By Stock
|
CMB |
Re:
Volume and price
|
|
TILLI
|
93 |
44K |
0 |
18/08/18 |
18/08/18 |
ASX - By Stock
|
93
|
44K
|
0
|
|
ASX - By Stock
|
CMB |
Re:
Volume and price
|
|
TILLI
|
93 |
44K |
1 |
18/08/18 |
18/08/18 |
ASX - By Stock
|
93
|
44K
|
1
|
|
ASX - By Stock
|
CMB |
Re:
Volume and price
|
|
TILLI
|
93 |
44K |
1 |
19/07/18 |
19/07/18 |
ASX - By Stock
|
93
|
44K
|
1
|
|
ASX - By Stock
|
CMB |
Re:
Volume and price
|
|
TILLI
|
93 |
44K |
2 |
17/07/18 |
17/07/18 |
ASX - By Stock
|
93
|
44K
|
2
|
|
ASX - By Stock
|
CMB |
Re:
Ann: US Patent Office to allow key patent for Progenza
|
|
TILLI
|
26 |
15K |
2 |
11/07/18 |
11/07/18 |
ASX - By Stock
|
26
|
15K
|
2
|
|
ASX - By Stock
|
CMB |
Re:
Ann: US Patent Office to allow key patent for Progenza
|
|
TILLI
|
26 |
15K |
1 |
11/07/18 |
11/07/18 |
ASX - By Stock
|
26
|
15K
|
1
|
|
ASX - By Stock
|
CMB |
Re:
Volume and price
|
|
TILLI
|
93 |
44K |
5 |
11/07/18 |
11/07/18 |
ASX - By Stock
|
93
|
44K
|
5
|
|
ASX - By Stock
|
CMB |
Re:
Re-rate
|
|
TILLI
|
24 |
14K |
4 |
12/05/18 |
12/05/18 |
ASX - By Stock
|
24
|
14K
|
4
|
|
ASX - By Stock
|
CMB |
Re:
Budget R&D
|
|
TILLI
|
2 |
1.1K |
0 |
10/05/18 |
10/05/18 |
ASX - By Stock
|
2
|
1.1K
|
0
|
|
ASX - By Stock
|
CMB |
Re:
Re-rate
|
|
TILLI
|
24 |
14K |
4 |
09/05/18 |
09/05/18 |
ASX - By Stock
|
24
|
14K
|
4
|
|
ASX - By Stock
|
CMB |
Budget R&D
|
|
TILLI
|
2 |
1.1K |
1 |
09/05/18 |
09/05/18 |
ASX - By Stock
|
2
|
1.1K
|
1
|
|
ASX - By Stock
|
CMB |
Re:
Ann: Appendix 4C - Quarterly
|
|
TILLI
|
5 |
3.9K |
1 |
28/04/18 |
28/04/18 |
ASX - By Stock
|
5
|
3.9K
|
1
|
|
ASX - By Stock
|
CMB |
Re:
Ann: US patent allowed for Sygenus for acne
|
|
TILLI
|
10 |
5.7K |
3 |
09/04/18 |
09/04/18 |
ASX - By Stock
|
10
|
5.7K
|
3
|
|
ASX - By Stock
|
CMB |
Volume and price
|
|
TILLI
|
93 |
44K |
0 |
04/01/18 |
04/01/18 |
ASX - By Stock
|
93
|
44K
|
0
|
|
ASX - By Stock
|
CMB |
Re:
Edison report 70c target
|
|
TILLI
|
6 |
4.0K |
5 |
21/09/17 |
21/09/17 |
ASX - By Stock
|
6
|
4.0K
|
5
|
|
ASX - By Stock
|
CMB |
Re:
Edison report 70c target
|
|
TILLI
|
6 |
4.0K |
3 |
19/09/17 |
19/09/17 |
ASX - By Stock
|
6
|
4.0K
|
3
|
|
ASX - By Stock
|
CMB |
Re:
Bold but exciting statement
|
|
TILLI
|
3 |
1.5K |
0 |
18/08/17 |
18/08/17 |
ASX - By Stock
|
3
|
1.5K
|
0
|
|
ASX - By Stock
|
CMB |
Re:
Ann: Japanese Patent Office to grant key patent for Progenza
|
|
TILLI
|
21 |
11K |
0 |
30/05/17 |
30/05/17 |
ASX - By Stock
|
21
|
11K
|
0
|
|
ASX - By Stock
|
CMB |
Re:
Ann: Japanese Patent Office to grant key patent for Progenza
|
|
TILLI
|
21 |
11K |
1 |
26/05/17 |
26/05/17 |
ASX - By Stock
|
21
|
11K
|
1
|
|
ASX - By Stock
|
CMB |
Re:
Ann: Japanese Patent Office to grant key patent for Progenza
|
|
TILLI
|
21 |
11K |
2 |
24/05/17 |
24/05/17 |
ASX - By Stock
|
21
|
11K
|
2
|
|
ASX - By Stock
|
CMB |
Re:
Ann: Japanese Patent Office to grant key patent for Progenza
|
|
TILLI
|
21 |
11K |
3 |
24/05/17 |
24/05/17 |
ASX - By Stock
|
21
|
11K
|
3
|
|
ASX - By Stock
|
CMB |
Re:
Ann: Positive clinical trial results for Progenza
|
|
TILLI
|
13 |
4.5K |
2 |
23/05/17 |
23/05/17 |
ASX - By Stock
|
13
|
4.5K
|
2
|
|
ASX - By Stock
|
CMB |
Re:
Ann: Chinese patent granted on stem cell secretions technology
|
|
TILLI
|
11 |
4.6K |
0 |
06/04/17 |
06/04/17 |
ASX - By Stock
|
11
|
4.6K
|
0
|
|
ASX - By Stock
|
CMB |
Re:
Ann: Chinese patent granted on stem cell secretions technology
|
|
TILLI
|
11 |
4.6K |
7 |
02/04/17 |
02/04/17 |
ASX - By Stock
|
11
|
4.6K
|
7
|
|
ASX - By Stock
|
CMB |
Re:
Beaufort Securities - UK Broker Alert
|
|
TILLI
|
4 |
2.5K |
1 |
24/03/17 |
24/03/17 |
ASX - By Stock
|
4
|
2.5K
|
1
|
|
ASX - By Stock
|
CMB |
Re:
Ann: Appendix 3Y Change of Director's Interest Notice
|
|
TILLI
|
9 |
4.0K |
3 |
17/03/17 |
17/03/17 |
ASX - By Stock
|
9
|
4.0K
|
3
|
|
ASX - By Stock
|
CMB |
Re:
Ann: Appendix 3Y Change of Director's Interest Notice
|
|
TILLI
|
9 |
4.0K |
1 |
17/03/17 |
17/03/17 |
ASX - By Stock
|
9
|
4.0K
|
1
|
|
ASX - By Stock
|
CMB |
Re:
Ann: ARC grant to progress stem cell research for chronic pain-RGS.AX
|
|
TILLI
|
10 |
3.5K |
4 |
20/05/16 |
20/05/16 |
ASX - By Stock
|
10
|
3.5K
|
4
|
|
ASX - By Stock
|
CMB |
Re:
Ann: Appendix 4C - Quarterly-RGS.AX
|
|
TILLI
|
7 |
3.2K |
3 |
28/04/16 |
28/04/16 |
ASX - By Stock
|
7
|
3.2K
|
3
|
|
ASX - By Stock
|
TCL |
Re:
$11
|
|
TILLI
|
20 |
8.6K |
1 |
04/04/16 |
04/04/16 |
ASX - By Stock
|
20
|
8.6K
|
1
|
|
ASX - By Stock
|
CMB |
Re:
Ann: Response to ASX Price Query
|
|
TILLI
|
15 |
6.1K |
0 |
24/03/16 |
24/03/16 |
ASX - By Stock
|
15
|
6.1K
|
0
|
|
ASX - By Stock
|
EHE |
Re:
Why the sharp drop
|
|
TILLI
|
35 |
16K |
0 |
18/03/16 |
18/03/16 |
ASX - By Stock
|
35
|
16K
|
0
|
|
ASX - By Stock
|
CMB |
Re:
Ann: Response to ASX Price Query
|
|
TILLI
|
15 |
6.1K |
2 |
18/03/16 |
18/03/16 |
ASX - By Stock
|
15
|
6.1K
|
2
|
|
ASX - By Stock
|
CMB |
Re:
12 cent gap
|
|
TILLI
|
2 |
1.2K |
2 |
15/03/16 |
15/03/16 |
ASX - By Stock
|
2
|
1.2K
|
2
|
|
ASX - By Stock
|
CMB |
Re:
Ann: Response to ASX Price Query
|
|
TILLI
|
15 |
6.1K |
2 |
14/03/16 |
14/03/16 |
ASX - By Stock
|
15
|
6.1K
|
2
|
|
ASX - By Stock
|
CMB |
Re:
Ann: Response to ASX Price Query
|
|
TILLI
|
15 |
6.1K |
4 |
11/03/16 |
11/03/16 |
ASX - By Stock
|
15
|
6.1K
|
4
|
|
ASX - By Stock
|
CMB |
Re:
Ann: Response to ASX Price Query
|
|
TILLI
|
15 |
6.1K |
0 |
11/03/16 |
11/03/16 |
ASX - By Stock
|
15
|
6.1K
|
0
|
|
ASX - By Stock
|
CMB |
Re:
Ann: Response to ASX Price Query
|
|
TILLI
|
15 |
6.1K |
0 |
09/03/16 |
09/03/16 |
ASX - By Stock
|
15
|
6.1K
|
0
|
|
ASX - By Stock
|
CMB |
Re:
New article
|
|
TILLI
|
20 |
7.4K |
0 |
09/03/16 |
09/03/16 |
ASX - By Stock
|
20
|
7.4K
|
0
|
|
ASX - By Stock
|
CMB |
Re:
New article
|
|
TILLI
|
20 |
7.4K |
1 |
08/03/16 |
08/03/16 |
ASX - By Stock
|
20
|
7.4K
|
1
|
|